Mazen M. Dimachkie. Optimizing chronic inflammatory demyelinating polyneuropathy care with subcutaneous immunoglobulin: The Polyneuropathy and Treatment with Hizentra Open-Label Extension (PATH OLE) study and beyond. rrnmf [Internet]. 2022 Jun. 22 [cited 2025 Apr. 18];3(2):13-26. Available from: https://journals.ku.edu/rrnmf/article/view/16304